Travere officer plans sale of 102,190 shares

Travere Therapeutics, Inc. (TVTX) discloses that officer Peter Heerma has filed a notice to sell up to 102,190 shares of common stock under Rule 144 through Morgan Stanley Smith Barney LLC, with sales expected to begin on or about September 15, 2026 on NASDAQ.

Rhea-AI Filing Summary

Travere Therapeutics, Inc. (TVTX) discloses that officer Peter Heerma has filed a notice to sell up to 102,190 shares of common stock under Rule 144 through Morgan Stanley Smith Barney LLC, with sales expected to begin on or about September 15, 2026 on NASDAQ.

The shares relate to equity compensation awards, including 77,190 shares from stock options exercisable for cash, and shares underlying restricted stock units and performance stock units that vested over the period from October 1, 2021 through January 31, 2025.

Key Figures

Shares of common stock to be sold: 102,190 shares Shares from stock options: 77,190 shares Shares from restricted stock units: 19,568 shares +3 more

6 metrics

Shares of common stock to be sold 102,190 shares Maximum number of Travere Therapeutics shares covered by the Rule 144 notice

Shares from stock options 77,190 shares Common shares to be sold arising from the exercise of stock options as of September 15, 2026

Shares from restricted stock units 19,568 shares Common shares related to restricted stock units dated October 1, 2021

Shares from performance stock units 5,432 shares Common shares related to performance stock units dated February 10, 2025

Expected sale commencement date September 15, 2026 Approximate date on or after which sales may begin under Rule 144

Notice signature date June 16, 2026 Date associated with the signed notice by Peter Heerma

Key Terms

Rule 144, restricted stock units, performance stock units

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock units financial

"Restricted Stock Units | Issuer | | | 19568 | 10/01/2021 | N/A"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

performance stock units financial

"Performance Stock Units | Issuer | | | 5432 | 02/10/2025 | N/A"

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider sale did TVTX disclose in this Form 144?

Travere Therapeutics disclosed that officer Peter Heerma filed a Rule 144 notice to sell up to 102,190 shares of common stock through Morgan Stanley Smith Barney LLC, with sales expected to begin on or about September 15, 2026 on NASDAQ.

How many Travere Therapeutics (TVTX) shares are tied to stock options in this filing?

The notice states that 77,190 shares of Travere Therapeutics common stock to be sold are associated with the exercise of stock options, with the exercise to be paid in cash as of September 15, 2026.

What RSU-related Travere Therapeutics (TVTX) shares are included in the Form 144?

The filing lists 19,568 shares of common stock associated with restricted stock units dated October 1, 2021. The remarks explain these securities were acquired upon vesting during the period from October 1, 2021 through January 31, 2025.

What performance stock units for TVTX are involved in this Form 144?

The notice includes 5,432 shares of common stock related to performance stock units dated February 10, 2025. These shares are part of the total 102,190 shares covered by the Rule 144 sale notice.

Which broker is handling the planned sale of TVTX shares under this Form 144?

The planned sale of Travere Therapeutics common stock is listed as being handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, in connection with the Rule 144 notice.

When was the Rule 144 notice for TVTX signed by Peter Heerma?

The notice is signed /s/ Peter Heerma, with a listed Date of Notice of June 16, 2026, while the expected date for beginning the sales is shown as September 15, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 04:42 PM Accepted by SEC EDGAR 09/15/2026 - 04:41 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001789617
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TRAVERE THERAPEUTICS, INC.
SEC File Number	001-36257
Address of Issuer	3611 Valley Centre Drive, Suite 300 San Diego CALIFORNIA 92130
Phone	8889697879
Name of Person for Whose Account the Securities are To Be Sold	PETER HEERMA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	102190	6723080.10	94261082	09/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2026	Exercise of Stock Options	Issuer			77190	09/15/2026	Cash
Common	10/01/2021	Restricted Stock Units	Issuer			19568	10/01/2021	N/A
Common	02/10/2025	Performance Stock Units	Issuer			5432	02/10/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 10/01/2021 through 01/31/2025.
Date of Notice	09/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/16/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Peter Heerma
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)